This bill amends section 68-911 of the Revised Statutes Supplement, 2025, to require the Nebraska Department of Health and Human Services to submit a state plan amendment by October 1, 2026, for the coverage of long-acting injectable and extended-release medications. These medications, which are approved by the federal Food and Drug Administration, are intended for individuals with serious mental illnesses or substance use disorders and can be administered in various settings, including hospitals and state psychiatric facilities.

Additionally, the bill repeals the original section 68-911, indicating a comprehensive update to the medical assistance coverage provisions. The inclusion of this new requirement reflects a commitment to enhancing mental health and substance use disorder treatment options within the state's medical assistance program.

Statutes affected:
Introduced: 68-911